Concepts (220)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognition Disorders | 8 | 2012 | 349 | 0.650 |
Why?
|
| Cognition | 7 | 2012 | 547 | 0.520 |
Why?
|
| Motor Activity | 3 | 2012 | 332 | 0.440 |
Why?
|
| Osteoarthritis, Knee | 4 | 2014 | 69 | 0.360 |
Why?
|
| Postmenopause | 10 | 2012 | 424 | 0.350 |
Why?
|
| Learning | 1 | 2011 | 84 | 0.320 |
Why?
|
| Tamoxifen | 2 | 2012 | 59 | 0.320 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2009 | 33 | 0.300 |
Why?
|
| Medroxyprogesterone Acetate | 5 | 2010 | 112 | 0.280 |
Why?
|
| Estrogens, Conjugated (USP) | 5 | 2010 | 157 | 0.260 |
Why?
|
| Women's Health | 5 | 2010 | 230 | 0.240 |
Why?
|
| Exercise Therapy | 3 | 2013 | 250 | 0.220 |
Why?
|
| Hot Flashes | 3 | 2014 | 49 | 0.220 |
Why?
|
| Aged | 22 | 2014 | 10263 | 0.220 |
Why?
|
| Breast Neoplasms | 3 | 2012 | 762 | 0.220 |
Why?
|
| Dementia | 4 | 2010 | 246 | 0.220 |
Why?
|
| Neuropsychological Tests | 4 | 2012 | 327 | 0.190 |
Why?
|
| Female | 30 | 2014 | 19945 | 0.180 |
Why?
|
| Obesity | 4 | 2013 | 1111 | 0.170 |
Why?
|
| Aging | 5 | 2012 | 942 | 0.170 |
Why?
|
| Estrogen Replacement Therapy | 4 | 2008 | 216 | 0.170 |
Why?
|
| Knee Joint | 2 | 2014 | 128 | 0.170 |
Why?
|
| Menopause | 2 | 2014 | 109 | 0.170 |
Why?
|
| Humans | 33 | 2014 | 32282 | 0.160 |
Why?
|
| Middle Aged | 19 | 2014 | 11851 | 0.150 |
Why?
|
| Weight-Bearing | 3 | 2014 | 42 | 0.150 |
Why?
|
| Mental Disorders | 3 | 2010 | 115 | 0.140 |
Why?
|
| Sexual Behavior | 2 | 2008 | 130 | 0.130 |
Why?
|
| Exercise | 2 | 2012 | 603 | 0.130 |
Why?
|
| Single-Blind Method | 3 | 2013 | 192 | 0.130 |
Why?
|
| Aged, 80 and over | 7 | 2012 | 3900 | 0.120 |
Why?
|
| Treatment Outcome | 7 | 2014 | 3416 | 0.120 |
Why?
|
| Pilot Projects | 3 | 2014 | 553 | 0.120 |
Why?
|
| Cohort Studies | 5 | 2011 | 1840 | 0.110 |
Why?
|
| Infant, Premature | 2 | 2007 | 74 | 0.110 |
Why?
|
| Telephone | 2 | 2012 | 61 | 0.110 |
Why?
|
| Weight Loss | 3 | 2013 | 410 | 0.110 |
Why?
|
| Abdominal Fat | 1 | 2014 | 39 | 0.110 |
Why?
|
| Subcutaneous Fat | 1 | 2014 | 44 | 0.100 |
Why?
|
| Cardiopulmonary Bypass | 2 | 2005 | 56 | 0.100 |
Why?
|
| Yoga | 1 | 2014 | 51 | 0.100 |
Why?
|
| Diet, Reducing | 1 | 2013 | 85 | 0.100 |
Why?
|
| Depression | 3 | 2012 | 420 | 0.100 |
Why?
|
| Affect | 1 | 2012 | 70 | 0.090 |
Why?
|
| Overweight | 1 | 2013 | 252 | 0.090 |
Why?
|
| Health Status | 2 | 2004 | 355 | 0.090 |
Why?
|
| Sexual Dysfunction, Physiological | 2 | 2008 | 19 | 0.090 |
Why?
|
| Mass Screening | 2 | 2011 | 256 | 0.090 |
Why?
|
| Physical Exertion | 1 | 2011 | 15 | 0.080 |
Why?
|
| Remote Consultation | 1 | 2011 | 14 | 0.080 |
Why?
|
| Health Services for the Aged | 1 | 2010 | 24 | 0.080 |
Why?
|
| Risk Factors | 5 | 2010 | 3934 | 0.080 |
Why?
|
| Energy Metabolism | 1 | 2011 | 153 | 0.080 |
Why?
|
| Mental Health Services | 1 | 2010 | 34 | 0.080 |
Why?
|
| Home Care Services | 1 | 2010 | 51 | 0.080 |
Why?
|
| Memory Disorders | 1 | 2010 | 49 | 0.080 |
Why?
|
| Male | 14 | 2014 | 19441 | 0.080 |
Why?
|
| Life Style | 1 | 2011 | 393 | 0.080 |
Why?
|
| Quality of Life | 4 | 2013 | 964 | 0.070 |
Why?
|
| Hormone Replacement Therapy | 1 | 2009 | 94 | 0.070 |
Why?
|
| Estrogens | 1 | 2010 | 194 | 0.070 |
Why?
|
| Hemostasis | 1 | 2008 | 8 | 0.070 |
Why?
|
| Running | 1 | 2008 | 20 | 0.070 |
Why?
|
| Acupuncture Therapy | 1 | 2008 | 19 | 0.070 |
Why?
|
| Knee Injuries | 1 | 2008 | 37 | 0.070 |
Why?
|
| Progesterone | 1 | 2008 | 78 | 0.070 |
Why?
|
| Memory | 1 | 2009 | 202 | 0.070 |
Why?
|
| Severity of Illness Index | 5 | 2014 | 853 | 0.070 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2007 | 8 | 0.060 |
Why?
|
| Child Health Services | 1 | 2007 | 24 | 0.060 |
Why?
|
| Training Support | 1 | 2006 | 6 | 0.060 |
Why?
|
| Continuity of Patient Care | 1 | 2007 | 73 | 0.060 |
Why?
|
| Women's Health Services | 1 | 2006 | 10 | 0.060 |
Why?
|
| Research Support as Topic | 1 | 2006 | 32 | 0.060 |
Why?
|
| Activities of Daily Living | 1 | 2006 | 245 | 0.060 |
Why?
|
| Lenses | 1 | 2005 | 1 | 0.060 |
Why?
|
| Night Blindness | 1 | 2005 | 1 | 0.060 |
Why?
|
| Sensory Aids | 1 | 2005 | 1 | 0.060 |
Why?
|
| Retinitis Pigmentosa | 1 | 2005 | 2 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2012 | 541 | 0.060 |
Why?
|
| Vision, Low | 1 | 2005 | 4 | 0.060 |
Why?
|
| Inflammation | 2 | 2013 | 506 | 0.060 |
Why?
|
| Nervous System Diseases | 1 | 2005 | 46 | 0.060 |
Why?
|
| Hyperglycemia | 1 | 2005 | 85 | 0.060 |
Why?
|
| Faculty, Medical | 1 | 2006 | 76 | 0.060 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2005 | 37 | 0.060 |
Why?
|
| Coronary Artery Bypass | 1 | 2005 | 100 | 0.060 |
Why?
|
| Academic Medical Centers | 1 | 2006 | 161 | 0.050 |
Why?
|
| Primary Health Care | 1 | 2007 | 232 | 0.050 |
Why?
|
| Body Mass Index | 3 | 2013 | 863 | 0.050 |
Why?
|
| Follow-Up Studies | 4 | 2011 | 2240 | 0.050 |
Why?
|
| Insulin | 2 | 2005 | 359 | 0.050 |
Why?
|
| Caloric Restriction | 1 | 2005 | 92 | 0.050 |
Why?
|
| Prospective Studies | 4 | 2012 | 2316 | 0.050 |
Why?
|
| Hippocampus | 1 | 2005 | 216 | 0.050 |
Why?
|
| Progesterone Congeners | 1 | 2003 | 22 | 0.050 |
Why?
|
| Mothers | 1 | 2004 | 74 | 0.050 |
Why?
|
| Perception | 1 | 2004 | 99 | 0.050 |
Why?
|
| Logistic Models | 3 | 2012 | 743 | 0.050 |
Why?
|
| alpha-Tocopherol | 1 | 2002 | 3 | 0.050 |
Why?
|
| Phytotherapy | 1 | 2003 | 36 | 0.050 |
Why?
|
| Soybeans | 1 | 2003 | 42 | 0.050 |
Why?
|
| Vitamin A | 1 | 2002 | 21 | 0.050 |
Why?
|
| Mucous Membrane | 1 | 2002 | 27 | 0.050 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2002 | 17 | 0.050 |
Why?
|
| Isoflavones | 1 | 2003 | 103 | 0.050 |
Why?
|
| Intraoperative Care | 1 | 2002 | 52 | 0.050 |
Why?
|
| Cardiotonic Agents | 1 | 2002 | 41 | 0.050 |
Why?
|
| Soybean Proteins | 1 | 2003 | 101 | 0.050 |
Why?
|
| Adaptation, Psychological | 1 | 2003 | 131 | 0.050 |
Why?
|
| Body Weight | 2 | 2014 | 323 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2002 | 186 | 0.040 |
Why?
|
| Stem Cell Transplantation | 1 | 2002 | 221 | 0.040 |
Why?
|
| North Carolina | 3 | 2012 | 1300 | 0.040 |
Why?
|
| Pain Measurement | 2 | 2013 | 341 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2008 | 1158 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2003 | 427 | 0.040 |
Why?
|
| Regression Analysis | 2 | 2014 | 273 | 0.040 |
Why?
|
| Proportional Hazards Models | 3 | 2008 | 773 | 0.040 |
Why?
|
| Time Factors | 3 | 2011 | 2205 | 0.040 |
Why?
|
| Pain | 2 | 2012 | 304 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 757 | 0.040 |
Why?
|
| Adult | 5 | 2012 | 9259 | 0.040 |
Why?
|
| Double-Blind Method | 3 | 2005 | 565 | 0.040 |
Why?
|
| United States | 4 | 2010 | 4072 | 0.030 |
Why?
|
| Linear Models | 2 | 2012 | 425 | 0.030 |
Why?
|
| Mobility Limitation | 2 | 2009 | 208 | 0.030 |
Why?
|
| Child Development | 2 | 2007 | 45 | 0.030 |
Why?
|
| Socioeconomic Factors | 2 | 2008 | 388 | 0.030 |
Why?
|
| Health Behavior | 2 | 2008 | 211 | 0.030 |
Why?
|
| Thigh | 1 | 2014 | 35 | 0.030 |
Why?
|
| Research Design | 2 | 2009 | 314 | 0.030 |
Why?
|
| Patellofemoral Joint | 1 | 2014 | 14 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2014 | 98 | 0.030 |
Why?
|
| Quadriceps Muscle | 1 | 2014 | 29 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2014 | 96 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2009 | 1224 | 0.030 |
Why?
|
| Gait | 1 | 2014 | 120 | 0.030 |
Why?
|
| Age Factors | 2 | 2008 | 1179 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2007 | 666 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2014 | 187 | 0.020 |
Why?
|
| Risk | 2 | 2004 | 305 | 0.020 |
Why?
|
| Incidence | 2 | 2008 | 1241 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2013 | 224 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2004 | 471 | 0.020 |
Why?
|
| Psychometrics | 1 | 2012 | 137 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2008 | 1479 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2011 | 73 | 0.020 |
Why?
|
| Drug Utilization | 1 | 2010 | 44 | 0.020 |
Why?
|
| Early Termination of Clinical Trials | 1 | 2010 | 4 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2010 | 31 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2010 | 101 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 276 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 907 | 0.020 |
Why?
|
| Protein C | 1 | 2008 | 2 | 0.020 |
Why?
|
| Factor VII | 1 | 2008 | 4 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2009 | 96 | 0.020 |
Why?
|
| Cumulative Trauma Disorders | 1 | 2008 | 13 | 0.020 |
Why?
|
| Placebo Effect | 1 | 2008 | 18 | 0.020 |
Why?
|
| Geriatric Assessment | 1 | 2011 | 335 | 0.020 |
Why?
|
| Antigens | 1 | 2008 | 34 | 0.020 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2008 | 42 | 0.020 |
Why?
|
| Anthropometry | 1 | 2008 | 89 | 0.020 |
Why?
|
| Libido | 1 | 2008 | 5 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2009 | 242 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2009 | 239 | 0.020 |
Why?
|
| Probability | 1 | 2008 | 155 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 595 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 555 | 0.020 |
Why?
|
| Erectile Dysfunction | 1 | 2008 | 69 | 0.020 |
Why?
|
| Infant Care | 1 | 2007 | 2 | 0.020 |
Why?
|
| Comprehensive Health Care | 1 | 2007 | 6 | 0.020 |
Why?
|
| Prevalence | 1 | 2010 | 955 | 0.020 |
Why?
|
| Algorithms | 1 | 2010 | 536 | 0.020 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2007 | 34 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2007 | 141 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 883 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 556 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2007 | 78 | 0.020 |
Why?
|
| Budgets | 1 | 2006 | 10 | 0.010 |
Why?
|
| Financing, Organized | 1 | 2006 | 17 | 0.010 |
Why?
|
| Sex Factors | 1 | 2008 | 655 | 0.010 |
Why?
|
| Benchmarking | 1 | 2006 | 24 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2007 | 456 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2007 | 477 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 2007 | 148 | 0.010 |
Why?
|
| Schools, Medical | 1 | 2006 | 43 | 0.010 |
Why?
|
| Patient Discharge | 1 | 2007 | 204 | 0.010 |
Why?
|
| Eye Protective Devices | 1 | 2005 | 4 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2005 | 165 | 0.010 |
Why?
|
| Electrochemistry | 1 | 2005 | 17 | 0.010 |
Why?
|
| Locomotion | 1 | 2005 | 34 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2006 | 171 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2005 | 83 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 2005 | 151 | 0.010 |
Why?
|
| Equipment Design | 1 | 2005 | 178 | 0.010 |
Why?
|
| Reference Values | 1 | 2005 | 238 | 0.010 |
Why?
|
| Maternal Behavior | 1 | 2004 | 3 | 0.010 |
Why?
|
| Mother-Child Relations | 1 | 2004 | 13 | 0.010 |
Why?
|
| Infant | 1 | 2007 | 1010 | 0.010 |
Why?
|
| Birth Weight | 1 | 2004 | 46 | 0.010 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2004 | 17 | 0.010 |
Why?
|
| Gestational Age | 1 | 2004 | 125 | 0.010 |
Why?
|
| Climacteric | 1 | 2003 | 6 | 0.010 |
Why?
|
| Tocopherols | 1 | 2002 | 4 | 0.010 |
Why?
|
| Herpes Zoster | 1 | 2002 | 12 | 0.010 |
Why?
|
| Leukemia | 1 | 2002 | 38 | 0.010 |
Why?
|
| Urinary Incontinence | 1 | 2003 | 68 | 0.010 |
Why?
|
| Lymphoma | 1 | 2002 | 37 | 0.010 |
Why?
|
| Social Support | 1 | 2003 | 180 | 0.010 |
Why?
|
| Young Adult | 1 | 2008 | 2649 | 0.010 |
Why?
|
| Dietary Supplements | 1 | 2003 | 188 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2002 | 197 | 0.010 |
Why?
|
| Length of Stay | 1 | 2002 | 321 | 0.010 |
Why?
|
| Rats | 1 | 2005 | 1895 | 0.010 |
Why?
|
| Survival Rate | 1 | 2002 | 893 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2002 | 484 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2002 | 417 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2002 | 823 | 0.010 |
Why?
|
| Animals | 1 | 2005 | 8199 | 0.010 |
Why?
|